| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |